Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_assertion type Assertion NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_head.
- NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_assertion description "[In multivariate analysis of all patients and those with advanced disease, serum trypsin-2-API concentration was an adverse prognostic factor for cancer-specific and progression-free survival, and it was independent of stage and histological type of the tumor (P <or= 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_provenance.
- NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_assertion evidence source_evidence_literature NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_provenance.
- NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_assertion SIO_000772 15269150 NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_provenance.
- NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_assertion wasDerivedFrom befree-20150227 NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_provenance.
- NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_assertion wasGeneratedBy ECO_0000203 NP630774.RApVnIHY_kOKxkXUwzk_9IBIIyXfKdybKZROn7a72JwzM130_provenance.